BriaCell Therapeutics (BCTX) Common Equity (2019 - 2026)
BriaCell Therapeutics (BCTX) reported Common Equity of $23.41 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 96.0% from $11.94 million a year earlier but down 22.5% from the prior quarter.
Powered by 
Analysis
BriaCell Therapeutics (BCTX) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Jul 31, 2025), BriaCell Therapeutics posted Common Equity of $17.33 million.
- By fiscal year, Common Equity came in at -$2.68 million in FY2024, -$3.78 million in FY2023, $10.33 million in FY2022 (-62.7%) and $27.67 million in FY2021.
- Five-year quarterly Common Equity spans a low of -$8.32 million in fiscal Q2 2024 and a high of $30.21 million in fiscal Q2 2026.
- Year over year, Common Equity has now increased in each of the last three quarters, with growth averaging 282.9% over the last four quarters.
- The high point for year-over-year Common Equity in five years was fiscal Q2 2026 (growth of 836.3%); the low point was fiscal Q1 2024 (a decline of 75.7%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $30.21 million (Q2 2026), $9.35 million (Q1 2026) and $17.33 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | BriaCell Therapeutics | 30.16 Mn | 29.51 Mn | - | 23.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 23.41 Mn |
| Jan 31, 2026 | 30.21 Mn |
| Oct 31, 2025 | 9.35 Mn |
| Jul 31, 2025 | 17.33 Mn |
| Apr 30, 2025 | 11.94 Mn |
| Jan 31, 2025 | 3.23 Mn |
| Oct 31, 2024 | 3.71 Mn |
| Jul 31, 2024 | -2.68 Mn |
| Apr 30, 2024 | -6.23 Mn |
| Jan 31, 2024 | -8.32 Mn |
| Oct 31, 2023 | 2.52 Mn |
| Jul 31, 2023 | -3.78 Mn |
| Apr 30, 2023 | -5.89 Mn |
| Jan 31, 2023 | -1.28 Mn |
| Oct 31, 2022 | 10.33 Mn |
| Jul 31, 2022 | 10.33 Mn |
| Apr 30, 2022 | 9.96 Mn |
| Jan 31, 2022 | 16.43 Mn |
| Oct 31, 2021 | 1.58 Mn |
| Jul 31, 2021 | 27.67 Mn |
API Access
BriaCell Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();